Antithrombotic Therapy in the Prevention of Stroke
Overview: Ischemic stroke is a leading cause of death and disability throughout the world. Antithrombotic therapy, which includes both antiplatelet and anticoagulant agents, is a primary medication of choice for the secondary prevention of stroke. However, the choices vary with the need to incorpora...
Main Authors: | Shyamal Bir, Roger E. Kelley |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/12/1906 |
Similar Items
-
Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
by: Ma Y, et al.
Published: (2018-05-01) -
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
by: Srivastava Padma
Published: (2010-01-01) -
Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
by: Roberto Valvo, et al.
Published: (2019-05-01) -
Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01) -
Left Atrial Appendage Occlusion and Post-procedural Antithrombotic Management
by: Anders Kramer, et al.
Published: (2024-01-01)